Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lambert

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Protein Engineering|October 1, 1994
Mutational and structural analysis of the lectin activity in binding domain 2 of ricin B chainS M Lehar, J T Pedersen, R S Kamath, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cellsC F Scott, S Bolender, G D McIntyre, et al.
Blood|February 1, 1992
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusionM L Grossbard, A S Freedman, J Ritz, et al.
British Journal of Haematology|August 8, 1998
Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myelomaM L Grossbard, P Fidias, J Kinsella, et al.
Experimental Hematology|May 1, 1992
Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow culturesV F La Russa, J D Griffin, S W Kessler, et al.
Biochemical Society Transactions|August 1, 1987
The anatomy of a multifunctional enzymeJ R Coggins, K Duncan, I A Anton, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 11, 2010
UV inhibits allergic airways disease in mice by reducing effector CD4 T cellsJ P McGlade, D H Strickland, M J M Lambert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasmsM L Grossbard, J M Lambert, V S Goldmacher, et al.
International Journal of Immunopharmacology|August 1, 1993
Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusionS A Shah, J M Lambert, V S Goldmacher, et al.
Blood|May 1, 1993
Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphomaM L Grossbard, J G Gribben, A S Freedman, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Protein Engineering|October 1, 1994
Mutational and structural analysis of the lectin activity in binding domain 2 of ricin B chainS M Lehar, J T Pedersen, R S Kamath, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1989
Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cellsC F Scott, S Bolender, G D McIntyre, et al.
Blood|February 1, 1992
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusionM L Grossbard, A S Freedman, J Ritz, et al.
British Journal of Haematology|August 8, 1998
Anti-B4-blocked ricin: a phase II trial of 7 day continuous infusion in patients with multiple myelomaM L Grossbard, P Fidias, J Kinsella, et al.
Experimental Hematology|May 1, 1992
Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow culturesV F La Russa, J D Griffin, S W Kessler, et al.
Biochemical Society Transactions|August 1, 1987
The anatomy of a multifunctional enzymeJ R Coggins, K Duncan, I A Anton, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 11, 2010
UV inhibits allergic airways disease in mice by reducing effector CD4 T cellsJ P McGlade, D H Strickland, M J M Lambert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasmsM L Grossbard, J M Lambert, V S Goldmacher, et al.
International Journal of Immunopharmacology|August 1, 1993
Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusionS A Shah, J M Lambert, V S Goldmacher, et al.
Blood|May 1, 1993
Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphomaM L Grossbard, J G Gribben, A S Freedman, et al.
Pageof 10